Meta-analysis of the association between vitamin D and autoimmune thyroid disease

Nutrients

Volumn 7, Issue 4, 2015, Pages 2485-2498

  Wang, Jiying ^a   Lv, Shishi ^a   Chen, Guo ^a   Gao, Chenlin ^a   He, Jianhua ^a   Zhong, Haihua ^a   Xu, Yong ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune thyroid disease; Graves disease; Hashimoto thyroiditis; Meta analysis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

AUTOIMMUNE THYROIDITIS; BIBLIOGRAPHIC DATABASE; CHEMOLUMINESCENCE; DATA PROCESSING; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVES DISEASE; HASHIMOTO DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PROTEIN BINDING; RADIOIMMUNOASSAY; REVIEW; RISK ASSESSMENT; VITAMIN D DEFICIENCY; BLOOD; PREVALENCE;

GRAVES DISEASE; HUMANS; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84927929448     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7042485     Document Type: Review

References (54)

1. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
2. Lemire, J.M.; Adams, J.S.; Sakai, R.; Jordan, S.C. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Investig. 1984, 74, 657-661.
3. Rigby, W.F.; Stacy, T.; Fanger, M.W. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (Calcitriol). J. Clin. Investig. 1984, 74, 1451-1455.
4. Deluca, H.F.; Cantorna, M.T. Vitamin D: Its role and uses in immunology. FASEB J. 2001, 15, 2579-2585.
5. Abou-Raya, A.; Abou-Raya, S.; Helmii, M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: A randomized placebo-controlled trial. J. Rheumatol. 2013, 40, 265-272.
6. Grishkan, I.V.; Fairchild, A.N.; Calabresi, P.A.; Gocke, A.R. 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proc. Natl. Acad. Sci. USA 2013, 110, 21101-21106.
7. Ananthakrishnan, A.N.; Cagan, A.; Gainer, V.S.; Cheng, S.C.; Cai, T.; Szolovits, P.; Shaw, S.Y.; Churchill, S.; Karlson, E.W.; Murphy, S.N.; et al. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment. Pharmacol. Ther. 2014, 39, 1136-1142.
8. Skaaby, T.; Husemoen, L.L.; Thuesen, B.H.; Linneberg, A. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 2015, doi:10.1007/s12020-015-0547-4.
9. Verstuyf, A.; Carmeliet, G.; Bouillon, R.; Mathieu, C. Vitamin D: A pleiotropic hormone. Kidney Int. 2010, 78, 140-145.
10. Huang, Z.L. The Study on Relationship between Serum 25-Hydroxyvitamin D3 Concentration and Hashimoto Thyroiditis. Master Dissertation, Jilin University, Jilin, China, 2013.
11. Liu, X.H. The Study on Relation between Vitamin D3 Level and Immune Disorder in Patients with Autoimmune Thyroid Disease. Master Dissertation, Zhengzhou University, Zhengzhou, China, 2012.
12. Sezgin, G.; Esref, O.M. Relationship of vitamin D deficiency and autoimmune thyroid diseases. Eur. J. Internal Med. 2011, 22, 87.
13. Effraimidis, G.; Badenhoop, K.; Tijssen, J.G.; Wiersinga, W.M. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur. J. Endocrinol. 2012, 167, 43-48.
14. Wells, G.A.; Shea, B.; O'Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. Available online: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed on 1 December 2014).
15. Eliades, M.; Spyrou, E.; Agrawal, N.; Lazo, M.; Brancati, F.L.; Potter, J.J.; Koteish, A.A.; Clark, J.M. Guallar, E.; Hernaez, R. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2013, 38, 246-254.
16. Yasuda, T.; Okamoto, Y.; Hamada, N.; Miyashita, K.; Takahara, M.; Sakamoto, F.; Miyatsuka, T.; Kitamura, T.; Katakami, N.; Kawamori, D.; et al. Serum vitamin D levels are decreased in patients without remission of Graves' disease. Endocrine 2013, 43, 230-232.
17. Tamer, G.; Arik, S.; Tamer, I.; Coksert, D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 2011, 21, 891-896.
18. Yasuda, T.; Okamoto, Y.; Hamada, N.; Miyashita, K.; Takahara, M.; Sakamoto, F.; Miyatsuka, T.; Kitamura, T.; Katakami, N.; Kawamori, D.; et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine 2012, 42, 739-741.
19. Bozkurt, N.C.; Karbek, B.; Ucan, B.; Sahin, M.; Cakal, E.; Ozbek, M.; Delibasi, T. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr. Pract. 2013, 19, 479-484.
20. Han, Y.; Cheng, Y.K.; Chen, Y.J.; Li, Y. M.; Jiang, Y. Q.; Zhang, S. F. Abnormality of serum 25(OH)D level and its associations with hormones and auto-antibody in patients with Graves' disease. Chin. J. Clin. Res. 2013, 26, 642-646.
21. Miao, W.; Ma, J.; Guo, R.; Wang, Y. J.; Wang, G.; Guan, H. X. The correlation between serum 25(OH)D and Graves' disease. Chin. J. Pract. Med. 2013, 33, 394-395.
22. Zhang, H.; Liang, L.Y.; Xie, Z.J. Low Vitamin D status is associated with increased titers of thyroid stimulating hormone receptor antibodies in Graves' disease. Endocr. Pract. 2014, doi:10.4158/EP14191.OR.
23. Shin, D.Y.; Kim, K.J.; Kim, D.; Hwang, S.; Lee, E.J. Low serum vitamin D is associated with anti-thyroid peroxidase antibody in autoimmune thyroiditis. Yonsei Med. J. 2014, 55, 476-481.
24. Li, Y.B.; Xue, X.H.; Liu, S.W.; Xi, G.X.; Zhao, L. X.; Zhang, X.L. Serum vitamin D of early Graves' disease patients: A clinical research. Chin. Rem. Clin. 2014, 14, 242-243.
25. Kivity, S.; Agmon, L.N.; Zisappl, M.; Shapira, Y.; Nagy, E.V.; Dankó, K.; Szekanecz, Z.; Langevitz, P.; Shoenfeld, Y. Vitamin D and autoimmune thyroid diseases. Cell Mol. Immunol. 2011, 8, 243-247.
26. Jyotsna, V.P.; Sahoo, A.; Ksh, S.A.; Sreenivass, V.; Gupta, N. Bone mineral density in patients of Graves' disease pre- & post-treatment in a predominantly vitamin D deficient population. Indian J. Med. Res. 2012, 135, 36-41.
27. Mansournia, N.; Mansournia, M.A.; Saeedi, S.; Dehghan, J. The association between serum 25(OH)D levels and hypothyroid Hashimoto's thyroiditis. J. Endocrinol. Investig. 2014, 37, 473-476.
28. Xuan, L.Y.; Yang, Y.H.; Lai, X.Y. The association between the serum 25(OH)D3 of autoimmune thyroid diseases patients and the level of sFas. Shandong Med. J. 2014, 38, 61-63.
29. Zheng, Y.; Zheng, F.P.; Li, H. The relationship between the blood uric acid level of Graves' disease and bone mineral density of lumbar vertebra. Chin. J. Gerontol. 2014, 11, 3017-3019.
30. Wang, Y.C. Analysis of the Relationship between 25(OH)D, IGF-1 and Bone Metabolism in Patients with Graves' Disease. Master Dissertation, Anhui Medical University, Hefei, China, 2014.
31. Kang, D.H.; Wang, Y.; Cao, W.; Wang, P.; Zhang, H.M. Higher prevalence of vitamin D deficiency in female patients with Graves' disease. Acta Nutrimenta Sin. 2014, 35, 299-301.
32. Wang, Z.S.; Wu, Y.P.; Song, Q.H. Bone mineral density and bone metabolism of Graves' disease in premenopausal women. Guangdong Med. J. 2014, 35, 1743-1746.
33. Bellastella, G.; Maiorino, M.I.; Petrizzo, M.; de Bellis, A.; Capuano, A.; Esposito, K.; Giugliano, D. Vitamin D and autoimmunity: What happens in autoimmune polyendocrine syndromes? J. Endocrinol. Investig. 2015, doi:10.1007/s40618-014-0233-z.
34. Feng, M.; Li, H.; Chen, S.F.; Li, W.F.; Zhang, F.B. Polymorphism in the vitamin D receptor gene and risk of autoimmune thyroid disease: A meta-analysis. Endocrine 2013, 43, 318-326.
35. Tsatsoulis, A. The role of stress in the clinical expression of thyroid autoimmunity. Ann. N.Y. Acad. Sci. 2006, 1088, 382-395.
36. Mullins, R.J.; Cohen, S.B.; Webb, L.M.; Chernajovsky, Y.; Dayan, C.M.; Londei, M.; Feldmann, M. Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barrvirus-transformed B cell lines. J. Clin. Investig. 1995, 96, 30-37.
37. Kallmann, B.A.; Hüther, M.; Tubes, M.; Feldkamp, J.; Bertrams, J.; Gries, F.A.; Lampeter, E.F.; Kolb, H. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 1997, 46, 237-243.
38. Dogan, R.N.E.; Vasy, C. Absence of IL-4 and not suppression of the Th2 response, prevents development of experimental autoimmune thyroid Graves' disease. J. Immunol. 2003, 170, 2195-2204.
39. Karanikas, G.; Schuetz, M.;Wahl, K.; Paul, M.; Kontur, S.; Pietschmann, P.; Kletter, K.; Dudczak, R.; Willheim, M. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin. Endocrinol. (Oxf.) 2005, 63, 191-196.
40. Peng, D.; Xu, B.; Wang, Y.; Guo, H.; Jiang, Y. A high frequency of circulating Th22 and Th17 cells in patients with new onset Graves' disease. PLoS ONE 2013, 8, doi:10.1371/journal. pone.0068446.
41. Li, D.; Cai, W.; Gu, R.; Zhang, Y.; Zhang, H.; Tang, K.; Xu, P.; Katirai, F.; Shi, W.; Wang, L.; et al. Th17 cells plays a role in the pathogenesis of Hashimoto's thyroiditis in patients. Clin. Immunol. 2013, 149, 411-420.
42. Qin, Q.; Liu, P.; Liu, L.; Wang, R.; Yan, N.; Yang, J.; Wang, X.; Pandey, M.; Zhang, J.A. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease. Braz. J. Med. Biol. Res. 2012, 45, 1202-1208.
43. Ito, C.; Watanabe, M.; Okuda. N.; Watanabe, C.; Iwatani, Y. Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr. J. 2006, 53, 473-478.
44. Staeva-Vieira, T.P.; Freedman, L.P. 1,25-Dihydroxyvitamin D3 inhabit IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol. 2002, 168, 1181-1189.
45. Palmer, M.T.; Lee, Y.K.; Maynard, C.L.; Oliver, J.R.; Bikle, D.D.; Jetten, A.M.; Weaver, C.T. Lineage-specific Effects of 1, 25-Dihydroxyvitamin D3 on the development of effect CD4 T cells. J. Biol. Chem. 2011, 286, 997-1004.
46. Pichler, J.; Gerstmayr, M.; Szépfalusi, Z.; Urbanek, R.; Peterlik, M.; Willheim, M. 1α,25 (OH)2D3 inhabits not only Th1 but also Th2 differentiation in human blood T cells. Pediatr. Res. 2002, 52, 12-18.
47. Joshi, S.; Pantalena, L.C.; Liu, X.K.; Gaffen, S.L.; Liu, H.; Rohowsky-Kochan, C.; Ichiyama, K.; Yoshimura, A.; Steinman, L.; Christakos, S.; et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell Biol. 2011, 31, 3653-3669.
48. Muscogiuri, G.; Mitri, J.; Mathieu, C.; Badenhoop, K.; Tamer, G.; Orio, F.; Mezza, T.; Vieth, R.; Colao, A.; Pittas, A. Mchanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease. Eur. J. Endocrinol. 2014, 171, 101-110.
49. Zhang, Q.Q.; Sun, M.; Wang ,Z.X.; Fu, Q.; Shi, Y.; Yang, F.; Zheng, S.; Xu, J.J.; Huang, X.P.; Liu, X.Y.; Cui, D.; Yang, T. Relationship between serum 25-hydroxy vitamin D and thyroid autoimmunity among middle-aged and elderly individuals. Acta Univ. Med. Nanjing (Nat. Sci.) 2014, 34, 486-489.
50. Shin, D.; Hwang, S. Baseline vitamin D level could be a short-term prognostic marker in patients with Graves' disease. Thyroid 2011, 21, A48.
51. Kawakami-Tani, T.; Fukawa, E.; Tanaka, H.; Abe, Y.; Makino, I. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. Metabolism 1997, 46, 1184-1188.
52. De Remigis, P.; Vianale, L.; De Remingis, A.; Napolitano,G. Vitamin D and autoimmune thyroid disease (at): Preliminary results. Thyroid 2013, 23, A81-A82.
53. Amrein, K.; Zajic, P.; Schnedl, C.;Waltensdorfer, A.; Fruhwald, S.; Holl, A.; Purkart, T.; Wünsch, G.; Valentin, T.; Grisold, A.; et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit. Care 2014, 18, doi:10.1186/cc13790.
54. Lai, J.K.; Lucas, R.M.; Clements, M.S.; Harrison, S.L.; Banks, E. Assessing vitamin D status: Pitfalls for the unwary. Mol. Nutr. Food Res. 2010, 54, 1062-1071.